semaglutide before and after 1 year The Pros Cons of for Weight Loss semaglutide transformation Incredible Before &

What's New: July 2026 Update TRIUMPH-4 confirmed: Retatrutide 28.7% weight loss in Phase 3 (December 2025) final data, not preliminary TRIUMPH-1 CONFIRMED (May 21, 2026): 28.3% average weight loss at 80 weeks in 2,339 patients without diabetes pivotal trial met all primary endpoints Availability unchanged: Retatrutide still investigational, no FDA approval until late 2027 at earliest Tirzepatide still the best available option: 22.5% weight loss, FDA-approved, available today TRANSCEND-T2D-1 confirmed (June 2026): -2.0% HbA1c and 16.8% weight loss in type 2 diabetes patients a separate diabetes-specific Phase 3 program NDA timeline on track: industry estimates continue to expect Q4 2026 filing, following TRIUMPH-1's positive readout Introduction The evolution of weight loss medications has progressed rapidly from single-agonist drugs to multi-agonist approaches

While some people notice a decreased appetite and weight loss in the first four weeks of treatment, it can take several months for them to reach their goals

But the exact time doesnt matter

Four participants in both groups also discontinued for personal reasons, leaving a final cohort size of 46 cases and 45 controls

Using expired semaglutide is most likely not a good idea